Loading…
Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2
A library of the 8000 tripeptides derivable from coded amino acids was prepared in 20 sets of 400 using solid phase synthesis on a benzhydrylamine resin. The peptide mixtures, as C-terminal amides, were screened for inhibition of secreted alkaline phosphatase expression in a cellular (COS) system wh...
Saved in:
Published in: | Antiviral chemistry & chemotherapy 1994-04, Vol.5 (2), p.128-129 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 129 |
container_issue | 2 |
container_start_page | 128 |
container_title | Antiviral chemistry & chemotherapy |
container_volume | 5 |
creator | Coffen, D. L. Huang, T.-N. Ramer, S. E. West, R. C. Connell, E. V. Schutt, A. D. Hsu, M.-C. |
description | A library of the 8000 tripeptides derivable from coded amino acids was prepared in 20 sets of 400 using solid phase synthesis on a benzhydrylamine resin. The peptide mixtures, as C-terminal amides, were screened for inhibition of secreted alkaline phosphatase expression in a cellular (COS) system wherein a transfected SeAP gene construct was under control of the HIV-1 LTR promoter, activated by the product of a cotransfected HIV Tat gene construct. Thus, YPG-NH2 was discovered as an inhibitor of HIV-1 Tat function and then shown to block HIV replication in a CD4+ T-cell line (CEM) with IC50 = 35μM. |
doi_str_mv | 10.1177/095632029400500210 |
format | article |
fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_proquest_journals_2342379403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_095632029400500210</sage_id><sourcerecordid>2342379403</sourcerecordid><originalsourceid>FETCH-LOGICAL-p294t-f7fd5480fa9988073f1b1e2fd54e21a3d30de130c5751b43b65aa4c076f9f1d03</originalsourceid><addsrcrecordid>eNplkU9Lw0AQxRdRsFa_gKcFvcbO7uavN6m1LQQtUguewiTZbbekSdxNhRz87ia2oOBphsdv3vBmCLlmcMdYEIwg8nzBgUcugAfAGZyQAQcXHA6-f_qnPycX1m4BROiJaEC-HrXNqk9pWlopivTR7Nc0lpjTya4uqlaX605dyLrRuaSxTg2a9p7Oy41OdaOrsh-bzVcOo0tsKJY5XWmDBX2VdaEz_EHSljYbSZdG10ej98XUeZ7xS3KmsLDy6liH5O1pshzPnPhlOh8_xE7dJWocFajcc0NQGEVhCIFQLGWS96LkDEUuIJdMQOYFHktdkfoeoptB4KtIsRzEkNwcfGtTfeylbZJttTdltzLhwuUi6O4mOur2SKHNsFAGy0zbpDZ614VORBQCFz02OmAW1_LXiEHSvyL5_wrxDYmaeLM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2342379403</pqid></control><display><type>article</type><title>Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2</title><source>Publicly Available Content (ProQuest)</source><source>SAGE Journals Online Archive</source><creator>Coffen, D. L. ; Huang, T.-N. ; Ramer, S. E. ; West, R. C. ; Connell, E. V. ; Schutt, A. D. ; Hsu, M.-C.</creator><creatorcontrib>Coffen, D. L. ; Huang, T.-N. ; Ramer, S. E. ; West, R. C. ; Connell, E. V. ; Schutt, A. D. ; Hsu, M.-C.</creatorcontrib><description>A library of the 8000 tripeptides derivable from coded amino acids was prepared in 20 sets of 400 using solid phase synthesis on a benzhydrylamine resin. The peptide mixtures, as C-terminal amides, were screened for inhibition of secreted alkaline phosphatase expression in a cellular (COS) system wherein a transfected SeAP gene construct was under control of the HIV-1 LTR promoter, activated by the product of a cotransfected HIV Tat gene construct. Thus, YPG-NH2 was discovered as an inhibitor of HIV-1 Tat function and then shown to block HIV replication in a CD4+ T-cell line (CEM) with IC50 = 35μM.</description><identifier>ISSN: 2040-2066</identifier><identifier>ISSN: 0956-3202</identifier><identifier>EISSN: 2040-2066</identifier><identifier>DOI: 10.1177/095632029400500210</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Alkaline phosphatase ; Amides ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; CD4 antigen ; HIV ; Human immunodeficiency virus ; Lymphocytes T ; Medical sciences ; Peptides ; Pharmacology. Drug treatments ; Replication ; Solid phase methods ; Tat gene ; Tat protein</subject><ispartof>Antiviral chemistry & chemotherapy, 1994-04, Vol.5 (2), p.128-129</ispartof><rights>1994 SAGE Publications</rights><rights>1994 INIST-CNRS</rights><rights>1994 SAGE Publications. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/095632029400500210$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2342379403?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,21860,25753,27924,27925,37012,44590,44857,45245</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3980233$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Coffen, D. L.</creatorcontrib><creatorcontrib>Huang, T.-N.</creatorcontrib><creatorcontrib>Ramer, S. E.</creatorcontrib><creatorcontrib>West, R. C.</creatorcontrib><creatorcontrib>Connell, E. V.</creatorcontrib><creatorcontrib>Schutt, A. D.</creatorcontrib><creatorcontrib>Hsu, M.-C.</creatorcontrib><title>Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2</title><title>Antiviral chemistry & chemotherapy</title><description>A library of the 8000 tripeptides derivable from coded amino acids was prepared in 20 sets of 400 using solid phase synthesis on a benzhydrylamine resin. The peptide mixtures, as C-terminal amides, were screened for inhibition of secreted alkaline phosphatase expression in a cellular (COS) system wherein a transfected SeAP gene construct was under control of the HIV-1 LTR promoter, activated by the product of a cotransfected HIV Tat gene construct. Thus, YPG-NH2 was discovered as an inhibitor of HIV-1 Tat function and then shown to block HIV replication in a CD4+ T-cell line (CEM) with IC50 = 35μM.</description><subject>Alkaline phosphatase</subject><subject>Amides</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>CD4 antigen</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Lymphocytes T</subject><subject>Medical sciences</subject><subject>Peptides</subject><subject>Pharmacology. Drug treatments</subject><subject>Replication</subject><subject>Solid phase methods</subject><subject>Tat gene</subject><subject>Tat protein</subject><issn>2040-2066</issn><issn>0956-3202</issn><issn>2040-2066</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNplkU9Lw0AQxRdRsFa_gKcFvcbO7uavN6m1LQQtUguewiTZbbekSdxNhRz87ia2oOBphsdv3vBmCLlmcMdYEIwg8nzBgUcugAfAGZyQAQcXHA6-f_qnPycX1m4BROiJaEC-HrXNqk9pWlopivTR7Nc0lpjTya4uqlaX605dyLrRuaSxTg2a9p7Oy41OdaOrsh-bzVcOo0tsKJY5XWmDBX2VdaEz_EHSljYbSZdG10ej98XUeZ7xS3KmsLDy6liH5O1pshzPnPhlOh8_xE7dJWocFajcc0NQGEVhCIFQLGWS96LkDEUuIJdMQOYFHktdkfoeoptB4KtIsRzEkNwcfGtTfeylbZJttTdltzLhwuUi6O4mOur2SKHNsFAGy0zbpDZ614VORBQCFz02OmAW1_LXiEHSvyL5_wrxDYmaeLM</recordid><startdate>199404</startdate><enddate>199404</enddate><creator>Coffen, D. L.</creator><creator>Huang, T.-N.</creator><creator>Ramer, S. E.</creator><creator>West, R. C.</creator><creator>Connell, E. V.</creator><creator>Schutt, A. D.</creator><creator>Hsu, M.-C.</creator><general>SAGE Publications</general><general>International Medical Press</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>3V.</scope><scope>7QL</scope><scope>7QR</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>199404</creationdate><title>Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2</title><author>Coffen, D. L. ; Huang, T.-N. ; Ramer, S. E. ; West, R. C. ; Connell, E. V. ; Schutt, A. D. ; Hsu, M.-C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p294t-f7fd5480fa9988073f1b1e2fd54e21a3d30de130c5751b43b65aa4c076f9f1d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Alkaline phosphatase</topic><topic>Amides</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>CD4 antigen</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Lymphocytes T</topic><topic>Medical sciences</topic><topic>Peptides</topic><topic>Pharmacology. Drug treatments</topic><topic>Replication</topic><topic>Solid phase methods</topic><topic>Tat gene</topic><topic>Tat protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coffen, D. L.</creatorcontrib><creatorcontrib>Huang, T.-N.</creatorcontrib><creatorcontrib>Ramer, S. E.</creatorcontrib><creatorcontrib>West, R. C.</creatorcontrib><creatorcontrib>Connell, E. V.</creatorcontrib><creatorcontrib>Schutt, A. D.</creatorcontrib><creatorcontrib>Hsu, M.-C.</creatorcontrib><collection>Pascal-Francis</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Antiviral chemistry & chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coffen, D. L.</au><au>Huang, T.-N.</au><au>Ramer, S. E.</au><au>West, R. C.</au><au>Connell, E. V.</au><au>Schutt, A. D.</au><au>Hsu, M.-C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2</atitle><jtitle>Antiviral chemistry & chemotherapy</jtitle><date>1994-04</date><risdate>1994</risdate><volume>5</volume><issue>2</issue><spage>128</spage><epage>129</epage><pages>128-129</pages><issn>2040-2066</issn><issn>0956-3202</issn><eissn>2040-2066</eissn><abstract>A library of the 8000 tripeptides derivable from coded amino acids was prepared in 20 sets of 400 using solid phase synthesis on a benzhydrylamine resin. The peptide mixtures, as C-terminal amides, were screened for inhibition of secreted alkaline phosphatase expression in a cellular (COS) system wherein a transfected SeAP gene construct was under control of the HIV-1 LTR promoter, activated by the product of a cotransfected HIV Tat gene construct. Thus, YPG-NH2 was discovered as an inhibitor of HIV-1 Tat function and then shown to block HIV replication in a CD4+ T-cell line (CEM) with IC50 = 35μM.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/095632029400500210</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2040-2066 |
ispartof | Antiviral chemistry & chemotherapy, 1994-04, Vol.5 (2), p.128-129 |
issn | 2040-2066 0956-3202 2040-2066 |
language | eng |
recordid | cdi_proquest_journals_2342379403 |
source | Publicly Available Content (ProQuest); SAGE Journals Online Archive |
subjects | Alkaline phosphatase Amides Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences CD4 antigen HIV Human immunodeficiency virus Lymphocytes T Medical sciences Peptides Pharmacology. Drug treatments Replication Solid phase methods Tat gene Tat protein |
title | Discovery of a Drug Lead Employing a Peptide Library: Inhibition of HIV-1 Tat and Viral Replication by the Tripeptide YPG-NH2 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A06%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20a%20Drug%20Lead%20Employing%20a%20Peptide%20Library:%20Inhibition%20of%20HIV-1%20Tat%20and%20Viral%20Replication%20by%20the%20Tripeptide%20YPG-NH2&rft.jtitle=Antiviral%20chemistry%20&%20chemotherapy&rft.au=Coffen,%20D.%20L.&rft.date=1994-04&rft.volume=5&rft.issue=2&rft.spage=128&rft.epage=129&rft.pages=128-129&rft.issn=2040-2066&rft.eissn=2040-2066&rft_id=info:doi/10.1177/095632029400500210&rft_dat=%3Cproquest_pasca%3E2342379403%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p294t-f7fd5480fa9988073f1b1e2fd54e21a3d30de130c5751b43b65aa4c076f9f1d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2342379403&rft_id=info:pmid/&rft_sage_id=10.1177_095632029400500210&rfr_iscdi=true |